{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:18:30Z","timestamp":1780481910126,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.vaccine.2005.08.103","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T09:03:42Z","timestamp":1127207022000},"page":"1191-1204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation"],"prefix":"10.1016","volume":"24","author":[{"given":"Shigeto","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunori","family":"Sakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.08.103_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2005.08.103_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(00)75001-2","article-title":"Exploiting the immune system: toward new vaccines against intracellular bacteria","volume":"75","author":"Hess","year":"2000","journal-title":"Adv Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2005.08.103_bib3","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.4049\/jimmunol.165.11.6463","article-title":"Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans","volume":"165","author":"Geluk","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1073\/pnas.95.1.270","article-title":"Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis","volume":"95","author":"Lalvani","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.08.103_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.21.120601.141114","article-title":"CD8 T cell responses to infectious pathogens","volume":"21","author":"Wong","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.103_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+) and CD4(+) T-cell epitopes from antigen 85A","volume":"70","author":"McShane","year":"2002","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2005.08.103_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-138-7-200304010-00011","article-title":"Gene vaccines","volume":"138","author":"Srivastava","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2005.08.103_bib8","doi-asserted-by":"crossref","unstructured":"Okada M, Kishimoto T, editors, The potential application and limitation of cytokine\/growth factor manipulation in cancer therapy. In: Pusztai L, Lewis C, Yap E, editors. Cell proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth. Oxford University Press, 1996. p. 218\u2013244.","DOI":"10.1093\/oso\/9780198547914.003.0008"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2005.08.103_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2005.08.103_bib10","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0264-410X(99)00407-7","article-title":"Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers","volume":"18","author":"Le","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.08.103_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria","volume":"199","author":"Moore","year":"2004","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clim.1998.4616","article-title":"Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial","volume":"90","author":"Boyer","year":"1999","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.103_bib13","first-page":"971","article-title":"DNA vaccines: application to tuberculosis","volume":"2","author":"Huygen","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib14","first-page":"30","article-title":"DNA vaccines against tuberculosis","volume":"1","author":"Lowrie","year":"1999","journal-title":"Curr Opin Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.70.1.1","article-title":"The search for new vaccines against tuberculosis","volume":"70","author":"Orme","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.103_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00063198-200205000-00006","article-title":"Tuberculosis vaccine development","volume":"8","author":"Doherty","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.vaccine.2005.08.103_bib17","series-title":"Tuberculosis: pathogenesis, protection, and control","first-page":"113","article-title":"Guinea pig model of tuberculosis","author":"McMurray","year":"1994"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.103_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1286-4579(99)80046-X","article-title":"The potential use of heat-shock proteins to vaccinate against mycobacterial infections","volume":"1","author":"Silva","year":"1999","journal-title":"Microbes Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2005.08.103_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2005.08.103_bib20","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/S0264-410X(03)00378-5","article-title":"Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65","volume":"21","author":"Baek","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2005.08.103_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.gt.3301908","article-title":"Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis","volume":"10","author":"Lima","year":"2003","journal-title":"Gene Ther"},{"issue":"6741","key":"10.1016\/j.vaccine.2005.08.103_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","article-title":"Therapy of tuberculosis in mice by DNA vaccination","volume":"400","author":"Lowrie","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.103_bib24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/IAI.70.4.1949-1956.2002","article-title":"Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis","volume":"70","author":"Palendira","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.103_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2567.2003.01660.x","article-title":"The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guerin) in protecting against systemic Mycobacterim avium infection","volume":"109","author":"Martin","year":"2003","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.103_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/mthe.2002.0537","article-title":"Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma","volume":"5","author":"Tanaka","year":"2002","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clim.2004.04.001","article-title":"Hemagglutinating virus of Japan protein is efficient for induction of CD4(+) T-cell response by a hepatitis B core particle-based HIV vaccine","volume":"112","author":"Takeda","year":"2004","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.170.1.495","article-title":"HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses","volume":"170","author":"Sakaue","year":"2003","journal-title":"J Immunol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2005.08.103_bib29","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.vaccine.2005.01.057","article-title":"Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model","volume":"23","author":"Kita","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2005.08.103_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.141.5.1543","article-title":"IL-6\/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells","volume":"141","author":"Okada","year":"1988","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.103_bib31","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.4049\/jimmunol.122.6.2527","article-title":"The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent","volume":"122","author":"Okada","year":"1979","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.103_bib32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4049\/jimmunol.120.4.1097","article-title":"LPS-or 8Br-cyclic AMP-induced production of T cell-activating factor(s) in macrophage tumor cell line J774.1","volume":"120","author":"Okada","year":"1978","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.103_bib33","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1073\/pnas.78.12.7717","article-title":"Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules","volume":"78","author":"Okada","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.103_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.157.2.583","article-title":"B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation","volume":"157","author":"Okada","year":"1983","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/bbrc.2000.2558","article-title":"Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite","volume":"271","author":"Yoshida","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.103_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1006\/viro.1994.1211","article-title":"The glycoprotein B genes of Marek's disease virus serotypes 2 and 3: identification and expression by recombinant fowlpox viruses","volume":"200","author":"Yoshida","year":"1994","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.vaccine.2005.08.103_bib37","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1089\/hum.1997.8.17-2133","article-title":"Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer","volume":"8","author":"Saeki","year":"1997","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.103_bib38","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/IAI.72.4.2014-2021.2004","article-title":"Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB\/MPT51","volume":"72","author":"Miki","year":"2004","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.08.103_bib39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxg091","article-title":"Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis","volume":"15","author":"Dascher","year":"2003","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.103_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1099\/0022-1317-51-2-131","article-title":"Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate","volume":"51","author":"Sugawara","year":"2002","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virol.2003.08.003","article-title":"Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection","volume":"316","author":"Yoshida","year":"2003","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nbt0197-35","article-title":"Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo","volume":"15","author":"Lieschke","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.103_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0264-410X(03)00543-7","article-title":"Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo","volume":"22","author":"Lima","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2005.08.103_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.jbchem.a002916","article-title":"Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition","volume":"129","author":"Nakamura","year":"2001","journal-title":"J Biochem (Tokyo)"},{"issue":"5","key":"10.1016\/j.vaccine.2005.08.103_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/104303401300042366","article-title":"Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates","volume":"12","author":"Tsuboniwa","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.103_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0378-1135(03)00046-4","article-title":"Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting","volume":"93","author":"Vordermeier","year":"2003","journal-title":"Vet Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.103_bib47","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1128\/IAI.68.6.3674-3679.2000","article-title":"Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis","volume":"68","author":"Turner","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.103_bib48","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/IAI.71.4.2192-2198.2003","article-title":"Pulmonary necrosis resulting from DNA vaccination against tuberculosis","volume":"71","author":"Taylor","year":"2003","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2005.08.103_bib49","first-page":"1335","article-title":"The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector","volume":"57","author":"Tanaka","year":"1997","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.103_bib50","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.103_bib51","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1128\/IAI.70.4.2159-2165.2002","article-title":"Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis","volume":"70","author":"Chambers","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.08.103_bib52","unstructured":"National Institute of Allergy and Infectious Diseases. The Jordan Report: 20th Anniversary Accelerated Development of vaccines: <http:\/\/www.niaid.nih.gov\/dmid\/vaccines\/jordan20\/jordan20_2002.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05009345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05009345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:14:40Z","timestamp":1759400080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05009345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0264410X05009345"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.08.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.08.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}